Lisa Henderson - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Lisa Henderson's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Lisa Henderson

Lisa Henderson

Verified

VP, Editorial, Informa

New Jersey

Final Covers

Beauty , Wellness , Fitness

Doesn’t Cover

I'm a generalist, so it's always worth asking me!

Journalist Type

Seniority Positions

Medium Formats

Content

Total articles 191

  • Rare disease therapeutic development facing challenges

    By Lisa Henderson Verified| Informa Connect@ Industry experts point to a combination of factors negatively impacting the space, including IRA, funding and market access concerns. 2024 heralded many investment deals, as well as FDA approvals, in the rare disease space. For example, 26 of CDER’s 50 novel drug approvals (52%), were approved to treat rare or “orphan” diseases.

    By Lisa Henderson Verified · Informa Connect

    Mar. 03, 2025

  • Complying with trial registries and other global disclosure reporting requirements an ongoing challenge

    By Lisa Henderson Verified| Informa Connect@ Registering clinical trials globally, along with the ever-multiplying regulatory document landscape, can lead to untenable oversight and compliance issues. Since the year 2000, approximately two new trial registries have opened each year.

    By Lisa Henderson Verified · Informa Connect

    Jan. 15, 2025

  • Rare disease therapeutic development facing challenges

    By Lisa Henderson Verified| Informa Connect@ Industry experts point to a combination of factors negatively impacting the space, including IRA, funding and market access concerns. 2024 heralded many investment deals, as well as FDA approvals, in the rare disease space. For example, 26 of CDER’s 50 novel drug approvals (52%), were approved to treat rare or “orphan” diseases.

    By Lisa Henderson Verified · Informa Connect

    Mar. 03, 2025

As seen in

Company Info

Informa

Informa plc is a global leader in business intelligence, academic publishing, and events. Founded in 1998 through the merger of six companies, including the Taylor & Francis Group, Informa is headquartered in London and operates in over 50 offices worldwide, serving customers in more than 180 countries. The company offers a diverse range of services across various sectors. Its business intelligence division provides data-driven insights to support decision-making. Informa publishes academic journals and books under well-known brands like Taylor & Francis and Routledge. Additionally, it organizes conferences, exhibitions, and trade shows through its Informa Connect and Informa Markets divisions. Informa also delivers specialist media and content, including expert research and accredited training. Informa serves a wide array of industries, including biotech, healthcare, finance, and education, among others. The company continues to expand its global presence, recently entering a joint venture with Dubai World Trade Center.

London, England, United Kingdom

'+44 20 7017 5000

Founded: 1998